DHTKD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.900100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.917390E-01
Normal-vs-Stage2
8.415900E-02
Normal-vs-Stage3
1.050430E-02
Normal-vs-Stage4
2.422800E-01
Stage1-vs-Stage2
7.363600E-01
Stage1-vs-Stage3
4.988200E-02
Stage1-vs-Stage4
7.624000E-01
Stage2-vs-Stage3
6.273900E-02
Stage2-vs-Stage4
5.598200E-01
Stage3-vs-Stage4
1.540140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.202200E-02
Normal-vs-AfricanAmerican
4.279400E-01
Normal-vs-Asian
4.669700E-02
Caucasian-vs-AfricanAmerican
4.506400E-01
Caucasian-vs-Asian
1.259550E-01
AfricanAmerican-vs-Asian
1.895350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.595600E-02
Normal-vs-Female
1.033440E-01
Male-vs-Female
8.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.914030E-01
Normal-vs-Age(41-60Yrs)
1.493580E-01
Normal-vs-Age(61-80Yrs)
6.107700E-02
Normal-vs-Age(81-100Yrs)
1.076390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.036400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.572000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.802600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.964000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.666400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.717800E-01
Normal-vs-Daily Drinker
8.478300E-02
Normal-vs-Weekly Drinker
1.932580E-01
Normal-vs-Occasional Drinker
1.428780E-01
Normal-vs-Social Drinker
6.132300E-02
Non Drinker-vs-Daily Drinker
3.140400E-01
Non Drinker-vs-Weekly Drinker
8.746200E-01
Non Drinker-vs-Occasional Drinker
7.213400E-01
Non Drinker-vs-Social Drinker
6.636600E-01
Daily Drinker-vs-Weekly Drinker
4.537800E-01
Daily Drinker-vs-Occasional Drinker
5.286600E-01
Daily Drinker-vs-Social Drinker
5.729800E-01
Weekly Drinker-vs-Occasional Drinker
8.634000E-01
Weekly Drinker-vs-Social Drinker
7.871200E-01
Occasional Drinker-vs-Social Drinker
9.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.600200E-02
Normal-vs-Grade 2
1.526200E-02
Normal-vs-Grade 3
2.674400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.618400E-01
Grade 1-vs-Grade 3
4.188400E-01
Grade 1-vs-Grade 4
4.600200E-02
Grade 2-vs-Grade 3
1.682230E-01
Grade 2-vs-Grade 4
1.526200E-02
Grade 3-vs-Grade 4
2.674400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.507800E-02
Normal-vs-NonDiabetic
7.414400E-02
Diabetic-vs-NonDiabetic
9.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.857790E-01
Normal-vs-NoPancreatitis
7.371900E-02
Pancreatitis-vs-NoPancreatitis
8.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.306630E-01
Normal-vs-N1
7.018100E-02
N0-vs-N1
6.599200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.116200E-01
Normal-vs-TP53-NonMutant
3.223600E-01
TP53-Mutant-vs-TP53-NonMutant
6.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
